<table border="0" cellpadding="0" cellspacing="0" id="i164beb90-5d4d-45d2-84a1-fc8f2c4ee9f4" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1: Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin Hydrochloride Tablets 
			</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th stylecode="Lrule Rrule Toprule">Subject Groups: Metformin<br/>Hydrochloride Tablets <br/>dose<sup>a</sup> (number of subjects)</th>
<th stylecode="Lrule Rrule Toprule">C<sub>max</sub>
<sup>b</sup> (mcg/mL)</th>
<th stylecode="Lrule Rrule Toprule">T<sub>max</sub>
<sup>c</sup> (hrs)</th>
<th stylecode="Lrule Rrule Toprule">Renal <br/>Clearance <br/>(mL/min)</th>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="4">
<sup>a </sup>All doses given fasting except the first 18 doses of the multiple dose studies<br/>
<sup>b </sup>Peak plasma concentration<br/>
<sup>c </sup>Time to peak plasma concentration<br/>
<sup>d </sup>Combined results (average means) of five studies: mean age 32 years (range 23 to 59 years)<br/>
<sup>e </sup>Kinetic study done following dose 19, given fasting<br/>
<sup>f </sup>Elderly subjects, mean age 71 years (range 65 to 81 years)<br/>
<sup>g </sup>CL<sub>cr</sub> = creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>
<br/>
</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">   Healthy, nondiabetic adults:</content>
<br/>      500 mg single dose (24)<br/>      850 mg single dose (74)<sup>d</sup>
<br/>      850 mg three times daily for 19 doses<sup>e</sup> (9) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>1.03 (±0.33)<br/>1.6 (±0.38)<br/>2.01 (±0.42)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>2.75 (±0.81) <br/>2.64 (±0.82) <br/>1.79 (±0.94) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>600 (±132) <br/>552 (±139) <br/>642 (±173) <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">   Adults with type 2 diabetes:</content>
<br/>      850 mg single dose (23)<br/>      850 mg three times daily for 19 doses<sup>e</sup> (9) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>1.48 (±0.5)<br/>1.9 (±0.62)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>3.32 (±1.08) <br/>2.01 (±1.22) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>491 (±138) <br/>550 (±160) <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">   Elderly<sup>f</sup>, healthy nondiabetic adults:</content>
<br/>      850 mg single dose (12)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>2.45 (±0.7)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>2.71 (±1.05) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>412 (±98) <br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">   Renal-impaired adults:</content>
<br/>
<content stylecode="bold">      850 mg single dose</content>
<br/>
<content stylecode="bold">      Mild </content>(CL<sub>cr</sub>
<sup>g</sup> 61 to 90 mL/min) (5)<br/>
<content stylecode="bold">      Moderate</content> (CL<sub>cr</sub> 31 to 60 mL/min) (4)<br/>
<content stylecode="bold">      Severe</content> (CL<sub>cr</sub> 10 to 30 mL/min) (6)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>
<br/>1.86 (±0.52)<br/>4.12 (±1.83)<br/>3.93 (±0.92)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>
<br/>3.2 (±0.45) <br/>3.75 (±0.5) <br/>4.01 (±1.1) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>
<br/>384 (±122) <br/>108 (±57) <br/>130 (±90) <br/>
</td>
</tr>
</tbody>
</table>